IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP, LLC

Q1 2018 Holdings

Filed 2018-04-19 | 5 holdings | $29.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytomx Therapeutics, Inc.(CTMX)COM23284F105$29.0M1,020,34899.6%
Rhythm Pharmaceuticals, Inc.(RYTM)COM76243J105$79.2K3,981,4370.3%
Kala Pharmaceuticals Inc.COM483119103$26.2K1,654,4250.1%
Eleven Biotherapeutics, Inc.COM286221106$5.1K4,841,5910.0%
Zafgen, Inc.COM98885E103$1.6K210,3710.0%